These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9235095)

  • 1. [Calcium channel blockers and cardiovascular morbidity mortality].
    Robles NR
    An Med Interna; 1997 May; 14(5):217-9. PubMed ID: 9235095
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium channel blockers scare].
    Zimlichman R
    Harefuah; 1997 Feb; 132(3):223-5. PubMed ID: 9154732
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The ALLHAT study: contributions, limitations and prospectives].
    Mancia G
    Ital Heart J Suppl; 2003 Feb; 4(2):77-84. PubMed ID: 12762256
    [No Abstract]   [Full Text] [Related]  

  • 5. CCBs vs ACE inhibitors in patients with diabetes.
    Zamorski MA
    J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiometabolic risk-factor management.
    Ker J
    Cardiovasc J Afr; 2008; 19(4):222-4. PubMed ID: 18776972
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium channel blockers inferior to cheaper drugs.
    Josefson D
    BMJ; 2000 Sep; 321(7261):590. PubMed ID: 10977828
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium channel blockers: third-line antihypertensives.
    Prescrire Int; 2001 Aug; 10(54):121-3. PubMed ID: 11718186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium antagonists and their impact on risk of coronary disease].
    Roca-Cusachs A; Rodicio JL
    Med Clin (Barc); 1996 Oct; 107(14):533-4. PubMed ID: 8999212
    [No Abstract]   [Full Text] [Related]  

  • 10. Are new antihypertensive agents better than old antihypertensive agents in preventing cardiovascular complications?
    Dickerson LM; Carek PJ
    J Fam Pract; 2002 Jan; 51(1):9. PubMed ID: 11927051
    [No Abstract]   [Full Text] [Related]  

  • 11. Living up to 100 years of Bayer Healthcare cardiovascular protection - Bayer Healthcare Cardiovascular : 20 years of participation in the South African cardiovascular community.
    Cardiovasc J Afr; 2009; 20(1):91-4. PubMed ID: 19287826
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword.
    Zanchetti A
    Drugs; 1999; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium channel blockers. Consensus amid controversy.
    Kochar MS; Qurashi MI
    Postgrad Med; 1997 Dec; 102(6):127-8, 133-6. PubMed ID: 9406569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive drugs for CVD.
    Weir MR
    J Fam Pract; 2006 Oct; 55(10):889-91; author reply 891-2. PubMed ID: 17089475
    [No Abstract]   [Full Text] [Related]  

  • 15. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy.
    Leader S; Mallick R; Roht L
    J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-channel blockade and hypertension.
    Salpeter S
    N Engl J Med; 1999 Jul; 341(5):372-3. PubMed ID: 10428665
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium antagonists and cardiovascular events in patients with hypertension and diabetes.
    Alderman M; Madhavan S; Cohen H
    Lancet; 1998 Jan; 351(9097):216-7. PubMed ID: 9449897
    [No Abstract]   [Full Text] [Related]  

  • 18. Atorvastatin + amlodipine: new drug. Just a commercial ploy.
    Prescrire Int; 2007 Jun; 16(89):105. PubMed ID: 17582926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resp-informations].
    Bouvier-Colle MH; Cot M; Le Goaster C
    Rev Epidemiol Sante Publique; 2000 Apr; 48(2):215-24. PubMed ID: 10804430
    [No Abstract]   [Full Text] [Related]  

  • 20. [Large scale clinical trials of calcium channel blockers on the prevention of cardiovascular diseases].
    Shimamoto K
    Clin Calcium; 2005 Oct; 15(10):1609-14. PubMed ID: 16199905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.